SpaceX’s $75 billion IPO will exclude it from S&P 500 ETFs for at least two years due to unchanged index eligibility rules. SpaceX will sell 555.6 million shares in its IPO, raising $75 billion at a $1.77 trillion valuation, setting a record for public offerings. The compa
The hype around SpaceX’s blockbuster IPO has been near-impossible to ignore. The company set a fixed price of $135 per share, is targeting a record $75 billion raise on the Nasdaq under the ticker SPCX, and is scheduled to debut on June 12, making it the largest initial pu
3 Momentum Stocks That Could Soar Post-Market Volatility Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly... <
Anthropic's Claude Opus 4.8 identified a critical vulnerability in Zcash's Orchard privacy pool, exposing broader crypto security risks from advanced AI. A security researcher using Anthropic's Claude Opus 4.8 discovered a four-year-old flaw in Zcash's Orchard privacy pool
HIVE Digital Technologies reports fiscal 2026 revenue of $297.8 million, driven by Bitcoin mining and high-performance computing growth. HIVE Digital Technologies Ltd. (NASDAQ:HIVE) reported fiscal 2026 revenue of $297.8 million, up 158% year over year, as Bitcoin mining a
Benchmark maintains Buy rating on INDI with $8 target after the company agrees to purchase CMOS image sensor assets for €40 million. Indie Semiconductor (NASDAQ:INDI) will acquire ams OSRAM’s fabless CMOS image sensor business for €40 million. The deal includes €35 million
GoodRx introduces a new subscription plan targeting chronic condition patients to expand its recurring revenue stream. GoodRx (NASDAQ:GDRX) unveiled GoodRx Companion, a $14.99 monthly subscription service aimed at reducing routine healthcare costs for consumers. The offeri
This is why Maravai Lifesciences Holdings Inc. (MRVI) is a Top penny Stock in the Top Investors Portfolio Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) is one of the top penny stocks to buy in investors’ stock portfolio. On May 7, Maravai LifeSciences Holdings Inc. (NAS
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the top penny stocks to buy in investors' stock portfolio. On May 8, Stifel reiterated a Hold rating on Aclaris Therapeut
Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases Cabaletta Bio Inc. (NASDAQ:CABA) is one of the top penny stocks to buy in investors’ stock portfolio. On May 14, Cabaletta Bio Inc. (NASDAQ:CABA) delivered positive clinic
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.